Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-11-06

Clinical Trial Update: Renin Angiotensin System Study (RASS/B-RASS) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the Renin Angiotensin System study (RASS/B-RASS) for Type 1 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Michael Mauer, MD | Conditions: Type 1 Diabetes | Phase 2 | Status: COMPLETED